WASHINGTON – The FDA has announced a major recall of prazosin hydrochloride due to potential cancer risks.
Teva Pharmaceuticals USA and Amerisource Health Services have voluntarily recalled over 580,000 bottles of prazosin capsules across the nation.
Prazosin is commonly used to lower blood pressure and sometimes for PTSD-related sleep issues.
The FDA has classified the recall as Class II, indicating the presence of nitrosamine impurities, which may pose cancer risks.
